Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders -- New Phone

  Galectin Therapeutics to Hold Conference Call to Provide Update Following
Company's Annual Meeting of Shareholders -- New Phone Number for Audio Portion
                               of Presentation

PR Newswire

ATLANTA, May 23, 2013

ATLANTA, May 23, 2013 /PRNewswire/ -- Galectin Therapeutics (NASDAQ: GALT)
will host a conference call at 9:30 A.M. Eastern Time on Thursday, May 23,
2013, to provide an update following the Company's Annual Meeting of
Shareholders. Due to technological difficulties, a different phone number
than previously circulated will be used for accessing the call. The audio
portion of the call can now be accessed by dialing (888) 582-3528 (toll-free
within the United States) or (847) 944-7361 (toll, from outside the United
States).The passcode for participants is still 7827311#.

The conference call and presentation will be webcast live over the internet
and can be accessed by logging on to the Galectin Therapeutics website at
www.galectintherapeutics.com.

Please log in approximately 10 minutes before the event to ensure a timely
connection.

The webcast will also be archived on the Company's website.

About Galectin Therapeutics

Galectin Therapeutics (NASDAQ: GALT) is developing promising
carbohydrate-based therapies for fibrotic liver disease and cancer based on
the Company's unique understanding of galectin proteins, key mediators of
biologic function. We are leveraging extensive scientific and development
expertise as well as established relationships with external sources to
achieve cost effective and efficient development. We are pursuing a clear
development pathway to clinical enhancement and commercialization for our lead
compounds in liver fibrosis and cancer. Additional information is available at
http://www.galectintherapeutics.com.

SOURCE Galectin Therapeutics

Website: http://www.galectintherapeutics.com